Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 11—November 2017
Dispatch

Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada

Sarah K. BrodeComments to Author , Alex Marchand-Austin, Frances B. Jamieson, and Theodore K. Marras
Author affiliations: West Park Healthcare Centre, Toronto, Ontario, Canada (S.K. Brode); University of Toronto, Toronto (S.K. Brode, F.B. Jamieson, T.K. Marras); University Health Network and Sinai Health System, Toronto (S.K. Brode, T.K. Marras); Public Health Ontario, Toronto (A. Marchand-Austin, F.B. Jamieson)

Main Article

Table

Average number of patients per year who had nontuberculous mycobacteria isolated, by body site and species/complex, Ontario, Canada, 1998–2010*

Species Pulm Skin/soft tissue MS Lymph Blood/marrow GI/GU CNS Other
MAC 1,328 8 1 2 17 18 0.8 3
Mycobacterium xenopi 568 0.2 0.3 0 0.3 10 0.2 0.5
M. gordonae 338 0.2 0 0 0 6 0.1 0.3
M. fortuitum 131 2 0.8 0 2 3 0.2 1.2
M. abscessus 58 2 0.4 0.1 0.5 0.3 0 0.8
M. chelonae 40 3 1 0.2 0.5 0.7 0 1.0
M. simiae complex 42 0.6 0.3 0.1 0.5 0.7 0 0.5
M. kansasii 34 0.3 0.2 0 0.2 0.6 0 0.1
M. marinum 0 6 1.5 0 0 0 0 0.6
Other‡
92
0.8
0.5
0.1
1
2
0.1
0.3
All 2,631 22 6 3 22 41 1 8

*Contemporary Ontario population 11.3–13.2 million. CNS, central nervous system; GI, gastrointestinal system; GU, genitourinary system; lymph, lymphatic system; MAC, Mycobacterium avium complex; MS, musculoskeletal system; pulm, pulmonary system.
M. gordonae was excluded from the number of pulmonary disease cases but included in pulmonary and nonpulmonary isolation cases.
‡Other species most commonly identified (% of grand total over entire study period, average no. patients per year), for pulmonary isolates were M. mucogenicum (0.93%, 24.5), M. terrae complex (0.43%, 11.4), M. scrofulaceum (19%, 5), M. peregrinum (0.17%, 4.4), M. neoaurum (0.14%, 3.8), M. shimoidei (0.13%, 3.3), M. szulgai (0.12%, 3.2), M. celatum (0.09%, 2.4), M. malmoense (0.08%, 2.2), M. elephantis (0.08%, 2.1), and M. margeritense/M. smegmatis (0.06% each, 1.5 each) and for nonpulmonary isolates included M. mucogenicum (1.3%, 1.38), M. smegmatis (1.0%, 1.08), M. terrae complex (0.5%, 0.54), M. genavense (0.4%, 0.38), M. senegalense (0.2%, 0.23), M. malmoense/M. scrofulaceum/M. szulgai (0.15% each, 0.15 each), M. margeritense/M. shimoidei /M. elephantis (0.07% each, 0.08 each).

Main Article

Page created: October 17, 2017
Page updated: October 17, 2017
Page reviewed: October 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external